Disease | polycystic ovary syndrome |
Comorbidity | |hyperandrogenism |
Sentences | 72 |
PubMedID- 20663984 | polycystic ovary syndrome (pcos) is associated with hyperandrogenism and insulin resistance, possibly reflecting defects in skeletal muscle and adipocyte insulin signaling. |
PubMedID- 23876972 | Nevertheless, rad54b may contribute to hyperandrogenism in pcos patients. |
PubMedID- 21812961 | Women experiencing hyperandrogenism associated with polycystic ovarian syndrome (pcos) [6,7] and preeclampsia [8-10] have a higher-than-normal prevalence of small-for-gestational age deliveries [11-15]. |
PubMedID- 24116069 | hyperandrogenism in pcos, and inverse correlation between androgen receptor (ar) cag numbers and ar function, led us to hypothesize that cag length variations may affect pcos risk. |
PubMedID- 24428207 | Also metabolic characteristics, fasting insulin and homa-ir were comparable in pcos subjects with hyperandrogenism and the nonhyperandrogenic phenotype (anovu + pco). |
PubMedID- 22112520 | Loss of the ovarian apoptotic mechanism has been reported to account pcos appearance [11,30,31], with hyperandrogenism as one of the proposed mechanisms affecting the balance between the ovarian expression of pro and anti-apoptotic proteins [32]. |
PubMedID- 21577021 | Presence of oligo- and/or anovulation (anov) and hyperandrogenemia and/or hyperandrogenism (ha) with or without polycystic ovaries (pco)) appear to have a more adverse metabolic profile than patients diagnosed with the additional criteria introduced in 2003 (i.e. |
PubMedID- 24695544 | In human cultured theca cells, recombinant resistin triggered 17α-hydroxylase activity, a marker of ovarian hyperandrogenism in women with pcos [64]. |
PubMedID- 23812344 | Background: polycystic ovary syndrome (pcos) is associated with hyperandrogenism and an increased risk of type 2 diabetes and cardiovascular disease. |
PubMedID- 25554608 | hyperandrogenism in pcos may increase the risk of nafld indirectly by obesity, insulin resistance, and directly by the hepatotoxic effect. |
PubMedID- 21899727 | Whereas metformin alone did not significantly reduce the free androgen index in obese adolescents, the combination of metformin and flutamide was as effective as e2-p combination pills in reducing the hyperandrogenism associated with pcos [133]. |
PubMedID- 21427116 | In addition, pcos patients with or without hyperandrogenism, and pcos patients with persisting and resolved pcos all had lower matsuda insulin sensitivity index and increased insulinogenic index in comparison with controls. |
PubMedID- 22696150 | Although bmi and follicle counts were higher in the african american cohort this cannot be explained by higher rates of pcos, as women with pcos and hyperandrogenism, as well as other reproductive disorders were excluded. |
PubMedID- 24713888 | The assay may provide greater ability to distinguish ovarian hyperandrogenism in women with pcos from other disorders in which adrenal steroidogenesis is compromised, such as in nonclassic congenital adrenal hyperplasia. |
PubMedID- 22035022 | Background: obesity, insulin resistance and hyperandrogenism, crucial parameters of polycystic ovary syndrome (pcos) play significant pathophysiological roles in lipidemic aberrations associated within the syndrome. |
PubMedID- 21190873 | Among them, 42 cases who had a definitive diagnosis of pcos with hyperandrogenism based on rotterdam diagnostic criteria were recruited for the study and other causes of hyperandrogenemia had been excluded. |
PubMedID- 24901345 | Prevalence of metabolic syndrome is higher among non-obese pcos women with hyperandrogenism and menstrual irregularity in korea. |
PubMedID- 21521255 | All probands had pcos, defined by symptoms of anovulation and/or hyperandrogenism with polycystic ovaries on ultrasound. |
PubMedID- 24615662 | Normalization of lh secretion (and perhaps the consequent hyperandrogenism) in pcos may promote folliculogenesis and ovulation. |
PubMedID- 25514100 | Context: adrenal hyperandrogenism affects approximately 25% of polycystic ovary syndrome (pcos) patients but its relation to obesity is not totally understood. |
PubMedID- 23717068 | polycystic ovaries are likely associated with ovarian hyperandrogenism, hyperinsulinemia, and altered intraovarian paracrine signaling [3,4]. |
PubMedID- 22737168 | Both of central obesity and hyperandrogenism in pcos aggravate insulin resistance which promotes incidence of diabetes mellitus. |
Page: 1 2